Lamond A. David's Insider Trades & SAST Disclosures
Lamond A. David's most recent trade in Quince Therapeutics Inc was a trade of 47,587 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lamond A. David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 47,587 | 47,587 | - | - | Director Stock Option (right to buy) | |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 27,000 | 27,000 | - | - | Employee Stock Option (right to buy) | |
|
Quince Therapeutics Inc
|
David Lamond A. | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 12 Dec 2023 | 22,627 | 2,347,545 (7%) | 0% | 1.0 | 23,532 | Common Stock |
|
Quince Therapeutics Inc
|
A. David Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 12 Dec 2023 | 22,627 | 2,324,918 (7%) | 0% | 1 | 22,627 | Common Stock |
|
Quince Therapeutics Inc
|
A. David Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 12 Dec 2023 | 22,327 | 2,302,291 (7%) | 0% | 1.0 | 22,774 | Common Stock |
|
Quince Therapeutics Inc
|
A. Lamond David | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 12 Dec 2023 | 300 | 2,279,964 (7%) | 0% | 1 | 300 | Common Stock |
|
Quince Therapeutics Inc
|
David Lamond A. | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 05 Dec 2023 | 19,123 | 2,260,541 (7%) | 0% | 1.0 | 19,505 | Common Stock |
|
Quince Therapeutics Inc
|
Lamond A. David | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 05 Dec 2023 | 19,123 | 2,279,664 (7%) | 0% | 1.0 | 19,314 | Common Stock |
|
Quince Therapeutics Inc
|
A. Lamond David | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 05 Dec 2023 | 19,123 | 2,241,418 (7%) | 0% | 1.0 | 19,314 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 30 Aug 2023 | 41,026 | 2,179,161 (7%) | 0% | 1.3 | 54,154 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 30 Aug 2023 | 41,026 | 2,138,135 (7%) | 0% | 1.3 | 53,744 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 15 Aug 2023 | 117,348 | 2,072,343 (7%) | 0% | 1.3 | 151,379 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 15 Aug 2023 | 107,886 | 1,954,995 (6%) | 0% | 1.3 | 142,410 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 15 Aug 2023 | 24,766 | 2,097,109 (7%) | 0% | 1.3 | 31,948 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
|
Applied Molecular Transpor...
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
|
Applied Molecular Transpor...
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 20 May 2022 | 33,500 | 1,077,519 | - | 3.3 | 109,210 | Common Stock |
|
Applied Molecular Transpor...
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 20 May 2022 | 33,000 | 1,044,019 | - | 3.1 | 101,640 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 200,002 | 1,734,722 (5%) | 0% | - | Common Stock | |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 11,029 | 11,029 | - | - | Stock Option (right to buy) | |
|
Applied Molecular Transpor...
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 15,175 | 15,175 | - | - | Stock Option (Right to Buy) | |
|
Applied Molecular Transpor...
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 42.00 per share. | 06 Apr 2021 | 25,000 | 1,011,019 | - | 42 | 1,050,000 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 33.77 per share. | 24 Mar 2021 | 50,000 | 1,847,109 (6%) | 0% | 33.8 | 1,688,500 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2021 | 1,534,720 | 1,534,720 (5%) | 5% | 0 | Common Stock | |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 34.28 per share. | 04 Mar 2021 | 16,621 | 1,763,730 (6%) | 0% | 34.3 | 569,768 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 36.34 per share. | 04 Mar 2021 | 15,969 | 1,793,009 (6%) | 0% | 36.3 | 580,313 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 35.00 per share. | 04 Mar 2021 | 13,310 | 1,777,040 (6%) | 0% | 35 | 465,850 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 36.86 per share. | 04 Mar 2021 | 4,100 | 1,797,109 (6%) | 0% | 36.9 | 151,126 | Common Stock |
|
Applied Molecular Transpor...
|
David A. Lamond | None | 09 Jun 2020 | 914,589 | 914,589 | - | - | Common Stock | ||
|
Applied Molecular Transpor...
|
David A. Lamond | None | Grant, award, or other acquisition of securities at price $ 14.00 per share. | 09 Jun 2020 | 71,430 | 986,019 | - | 14 | 1,000,020 | Common Stock |
|
Applied Molecular Transpor...
|
David A. Lamond | None | 09 Jun 2020 | 1 | 0 | - | - | Series B Preferred Stock | ||
|
Applied Molecular Transpor...
|
David A. Lamond | None | 09 Jun 2020 | 1 | 0 | - | - | Series A Preferred Stock | ||
|
Applied Molecular Transpor...
|
David A. Lamond | None | 09 Jun 2020 | 1 | 0 | - | - | Series C Preferred Stock | ||
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 11,029 | 11,029 | - | - | Stock Option (Right to Buy) | |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 43.88 per share. | 04 Jun 2020 | 24,874 | 1,747,109 (5%) | 0% | 43.9 | 1,091,384 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 42.13 per share. | 04 Jun 2020 | 13,609 | 1,711,593 (5%) | 0% | 42.1 | 573,377 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 43.32 per share. | 04 Jun 2020 | 10,642 | 1,722,235 (5%) | 0% | 43.3 | 461,034 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 56.42 per share. | 15 May 2020 | 32,894 | 1,697,984 (5%) | 0% | 56.4 | 1,855,738 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 55.42 per share. | 15 May 2020 | 5,906 | 1,665,090 (5%) | 0% | 55.4 | 327,309 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 48.96 per share. | 15 May 2020 | 1,600 | 1,657,184 (5%) | 0% | 49.0 | 78,333 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 46.30 per share. | 15 May 2020 | 1,263 | 1,654,599 (5%) | 0% | 46.3 | 58,478 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 50.71 per share. | 15 May 2020 | 1,000 | 1,658,184 (5%) | 0% | 50.7 | 50,707 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 48.37 per share. | 15 May 2020 | 985 | 1,655,584 (5%) | 0% | 48.4 | 47,640 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 52.20 per share. | 15 May 2020 | 500 | 1,658,684 (5%) | 0% | 52.2 | 26,101 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 54.09 per share. | 15 May 2020 | 400 | 1,659,184 (5%) | 0% | 54.1 | 21,636 | Common Stock |
|
Quince Therapeutics Inc
|
David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 53.10 per share. | 15 May 2020 | 100 | 1,658,784 (5%) | 0% | 53.1 | 5,310 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges